Evidence map›Paper›PMID 33187475›Full record

ArticleBMC infectious diseases2020

Clinical and radiographic characteristics, management and short-term outcomes of patients with COVID-19 in Wenzhou, China.

Liang Hong, Enling Ye, Gangqiang Sun, Xiaoyang Wang, Shengguo Zhang, Yanghe Wu, Xiangao Xie, Shichun Xia, Xudong Zheng, Ling Dong and 7 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Liang HongDepartment of Infectious diseases, the Third Affiliated Hospital to Wenzhou Medical University (Ruian People's Hospital), 108 Wansong Road, Ruian, Wenzhou, 325200, Zhejiang Province, China.
Enling YeEndocrinology Department, the Third Affiliated Hospital to Wenzhou Medical University (Ruian People's Hospital), Ruian City, Zhejiang Province, 325200, China.
Gangqiang SunDepartment of Biology, Gordon College, Wenham, MA, 01984, USA.
Xiaoyang WangRadiography Department, the Third Affiliated Hospital to Wenzhou Medical University (Ruian People's Hospital), Ruian City, Zhejiang Province, 325200, China.
Shengguo ZhangDepartment of Infectious diseases, the Third Affiliated Hospital to Wenzhou Medical University (Ruian People's Hospital), 108 Wansong Road, Ruian, Wenzhou, 325200, Zhejiang Province, China.
Yanghe WuDepartment of Infectious diseases, the Third Affiliated Hospital to Wenzhou Medical University (Ruian People's Hospital), 108 Wansong Road, Ruian, Wenzhou, 325200, Zhejiang Province, China.
Xiangao XieHealth bureau of Ruian City, 333 Ruihu Road, Ruian, Wenzhou, 325200, Zhejiang Province, China.
Shichun XiaHospital Office, the Third Affiliated Hospital to Wenzhou Medical University (Ruian People's Hospital), Ruian City, Zhejiang Province, 325200, China.
Xudong ZhengThe Emergency Department, the Third Affiliated Hospital to Wenzhou Medical University (Ruian People's Hospital), Ruian City, Zhejiang Province, 325200, China.
Ling DongPneumology Department, the Third Affiliated Hospital to Wenzhou Medical University (Ruian People's Hospital), Ruian City, Zhejiang Province, 325200, China.
Fujing CaiDepartment of Infectious diseases, the Third Affiliated Hospital to Wenzhou Medical University (Ruian People's Hospital), 108 Wansong Road, Ruian, Wenzhou, 325200, Zhejiang Province, China.
Xixian LouPneumology Department, the Third Affiliated Hospital to Wenzhou Medical University (Ruian People's Hospital), Ruian City, Zhejiang Province, 325200, China.
Renguo ZhaoPneumology Department, the Third Affiliated Hospital to Wenzhou Medical University (Ruian People's Hospital), Ruian City, Zhejiang Province, 325200, China.
Yongqi HuThe Emergency Department, the Third Affiliated Hospital to Wenzhou Medical University (Ruian People's Hospital), Ruian City, Zhejiang Province, 325200, China.
Zhanwei RuanThe Emergency Department, the Third Affiliated Hospital to Wenzhou Medical University (Ruian People's Hospital), Ruian City, Zhejiang Province, 325200, China.
Jiguang DingDepartment of Infectious diseases, the Third Affiliated Hospital to Wenzhou Medical University (Ruian People's Hospital), 108 Wansong Road, Ruian, Wenzhou, 325200, Zhejiang Province, China. djg5011@163.com.
Qingfeng SunDepartment of Infectious diseases, the Third Affiliated Hospital to Wenzhou Medical University (Ruian People's Hospital), 108 Wansong Road, Ruian, Wenzhou, 325200, Zhejiang Province, China. sunxue0806@126.com.
Wenzhou Medical University · CNRuian People's Hospital · CNGordon College · US

Funding

Fund of Ruian Science and Technology Bureau MS2020023 and MS2020025
6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) is an emerging viral disease. Here, we report the clinical features, management, and short-term outcomes of COVID-19 patients in Wenzhou, China, an area outside Wuhan.

methodsPatients admitted to the Infectious Diseases Department of Ruian People's Hospital in Wenzhou, from January 21 to February 7, 2020, were recruited. Medical data on epidemiological history, demographics, clinical characteristics, laboratory tests, chest computerized tomography (CT) examination, treatment, and short-term outcomes were retrospectively reviewed. Blood biochemistry and routine tests were examined using standard methods and automatic machines. CT examination was performed several times during hospitalization as necessary.

resultsA total of 67 confirmed COVID-19 cases were diagnosed; 64 (95.4%) were common cases and three (4.5%) were severe cases. The most common symptoms at admission were fever (86.6%), cough (77.6%), productive cough (52.2%), chest distress (17.9%), and sore throat (11.9%), followed by diarrhea (7.4%), headache (7.4%), shortness of breath (6.0%), dizziness (4.5%), muscular soreness (4.5%), and running nose (4.5%). Thirty patients (47.8%) had increased C-reactive protein levels. The CT radiographs at admission showed abnormal findings in 54 (80.6%) patients. The patients were treated mainly by oxygen therapy and antiviral drugs. By March 3, 2020, all 67 patients completely recovered and had negative nucleic acid tests. The patients were discharged from the hospital and transferred to a medical observation isolation center for further observation.

conclusionCases of COVID-19 in Wenzhou are milder and have a better prognosis, compared to those in Wuhan. Timely and appropriate screening, diagnosis, and treatment are the key to achieve good outcomes.

Indexed as

BetacoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralAdolescentAdultAgedAntiviral AgentsChildChild, PreschoolChinaComorbidityCoughCOVID-19DiarrheaFemaleAntiviral AgentsClinicalCOVID-19EpidemiologyRadiographic characteristicsSARS-cov-2

Identifiers

PMID33187475
PMCPMC7662018
OpenAlexW3098951760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.